Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients - Concepedia

Concepedia

Publication | Open Access

Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients

DOI Full Paper Access

34

Citations

31

References

2017

Year

Bei‐Ge Jiang, Neng Wang, Jian Huang, Yuan Yang, Liangliang Sun, Ze‐Ya Pan, Weiping Zhou

Abstract

This finding suggests that the presence of SOCS3 methylation is a marker to predict treatment response and prognosis in HCC patients receiving TACE therapy.

References

	Year	Citations

Page 1